Perrigo Company plc Ordinary Shares (PRGO): Price and Financial Metrics

PRGO Stock Price Chart Interactive Chart >

PRGO Price/Volume Stats

Perrigo Company plc Ordinary Shares (PRGO) Company Bio

Perrigo Company develops, manufactures, and distributes generic prescription pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients and pharmaceutical and medical diagnostic products. The company was founded in 1887 and is based in Dublin, Ireland.

PRGO Price Forecast Based on DCF Valuation

Below please find a table outlining a discounted cash flow forecast for PRGO, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that PERRIGO Co plc ranked in the 17th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of PERRIGO Co plc, consider:

• The stock's equity weight, or the proportion of capital from equity relative to debt, is 61. Notably, its equity weight is greater than merely 16.23% of US equities in the Healthcare sector yielding a positive free cash flow.
• Its compound free cash flow growth rate, as measured over the past 5.55 years, is -0.14% -- higher than merely 11.3% of stocks in our DCF forecasting set.
• PERRIGO Co plc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than merely 0% of US stocks with positive free cash flow.

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as PRGO, try ZBH, BHC, IIN, LCI, and MD.